Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy.
Pediatr Hematol Oncol., Mar;27(2):112-21 (2010)
Altered iron metabolism in children with human immunodeficiency virus disease.
Pediatr Hematol Oncol., Mar;26(2):69-84 (2009)
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial.
Haematologica., Jun;93(6):817-25 (2008)
Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.
Br. J. Haematol., Oct;135(2):254-63 (2006)
Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
Pediatr Blood Cancer., Sep;49(3):329-32 (2007)
Iron homeostasis during transfusional iron overload in beta-thalassemia and sickle cell disease: changes in iron regulatory protein, hepcidin, and ferritin expression.
Pediatr Hematol Oncol., Jun;24(4):237-43 (2007)
Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis.
Am. J. Clin. Pathol., Jan;123(1):146-52 (2005)
Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia.
Am. J. Hematol., Sep;80(1):70-4 (2005)
Treatment of hepatitis C virus infection in thalassemia.
Ann. N. Y. Acad. Sci., 1054:290-9 (2005)
Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia.
Haematologica., Aug;93(8):1247-51 (2008)
A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.
Ann. N. Y. Acad. Sci., 1054:486-91 (2005)
Follow-up report on the 2-year cardiac data from a deferasirox monotherapy trial.
Am. J. Hematol., Oct;85(10):818-9 (2010)
Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial.
Haematologica., Jul;96(7):1055-8 (2011)
Pulmonary function in thalassaemia major and its correlation with body iron stores.
Br. J. Haematol., Oct;155(1):102-5 (2011)
The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores.
Blood., Jul;116(4):537-43 (2010)
Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease.
Am. J. Clin. Nutr., Feb;89(2):545-50 (2009)
Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator.
Br. J. Haematol., Aug;138(3):374-81 (2007)